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ABSTRACT 
 
Introduction: Limb girdle weakness is one of the frequent clinical diagnoses in neurological clinics. Their etiology, 
treatment and prognosis are varied in different geographical regions of the world.  Materials and methods: Patient 
cohort of 68 patients with limb girdle weakness from a tertiary hospital in South India were studied. Results: Most 
of the patients were found to have muscular dystrophies with LGMD variety being the highest reported. Out of 48 
cases of muscle disorders LGMD [17/48] and DMD [14/48] formed the majority. Very few of them had a family 
history and they had little evidence of cardiac involvement. Males were more affected in DMD and BMD. LGMD 
males outnumbered female patients in this study. Conclusion: Our study reports that muscular dystrophies claim a 
major share of limb girdle weakness. It is very important to understand the precise etiology and to identify patients 
prone to life threatening cardiac, pharyngeal or respiratory muscle involvement. 
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Introduction 
The term “limb girdle weakness” refers to a clinically 
heterogeneous group of disorders mainly characterized 
by proximal muscle weakness of the shoulder girdle 
and pelvic girdle. Typically patients with hip girdle 
weakness manifest with difficulty in getting up from 
floor or a toilet without hand rails. People with 
quadriceps weakness find great difficulty in descending 
stairs and those with hip extensor weakness while 
climbing up the steps. Weakness of hip abductors, 
results in Trendlenburg gait. In patients with shoulder 
girdle weakness, a feeling of tiredness often is the first 
expression as the weight of arm is sufficient to cause 
fatigue.  Patients experience fatigue on performing 
sustained tasks with hands held up, especially over the 
head.  The problematic activities include painting the 
ceiling, shampooing, shaving or trying to lift   an object 
off a high shelf [1].  
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As these are the symptoms with which patients present 
to the clinics, the distribution of various etiologies 
causing these symptoms is useful for diagnosis. 
Regional information regarding the relative frequencies 
and morbidities associated with these diseases can help 
to understand the priorities for public health planning 
and research. The etiological and clinical profile is also 
different in different countries. We present our profile 
of patients presenting with Limb Girdle Muscle 
Weakness to a tertiary neurocare centre in a developing 
country. 
Materials and methods 
This is an observational study of patients admitted in 
the Neurology Department, Osmania Medical College 
and Hospital and in Niloufer Paediatric Hospital, 
Hyderabad, India with features suggestive of limb 
girdle weakness. Sixty eight patients were evaluated in 
the Department of Neurology, Osmania General 
Hospital, Hyderabad between October 2008 and 
January 2011.Cases were chosen based on the 
diagnosis by  Clinical examination in all affected 
patients and family members, the family members were 
considered to be symptomatic if they had hypertrophy 
of any muscles with or without weakness.  The cranial 
nerve involvement (especially facial, ocular and 
bulbar) pattern of wasting, atrophy and hypertrophy 
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(symmetrical or asymmetrical) of muscles were noted. 
For all the patients, muscle biopsy, 
immunohistochemistry, CPK [creatinine 
phosphokinase] levels in the blood and other routine 
blood investigations were carried out.  
Patients with predominant distal muscle weakness, 
combined  LMN [lower motor neuron] and UMN 
[upper motor neuron] weakness , generalized weakness 
and Onset of the disease at birth were excluded from 
study. 
The study was approved by the Institutional Ethical 
Committee and informed consent was obtained from 
patients. 
Results  
During the study period a total of 68 patients with limb 
girdle weakness were examined.  
 
Figure 1: Distribution of limb girdle weakness 
 
Muscle disorders constituted the majority [48/68] of cases . Forty two  of these were muscular dystrophies. 
Neurogenic causes formed a significant number, among which most of the patients [15/18] were diagnosed with 
CIDP [chronic inflammatory demyelinating neuropathy] 
Table 1: Muscle disorders  
Diseases No of patients  Percentage 
Muscular dystrophies  42 87.5 
Metabolic myopathy  5 10.4 
Polymyositis  1 1.1 
              42 cases of  muscle disorders were muscular dystrophies of all the cases. 
Table 2: Family History and Limb girdle weakness 
Disease  No of patients with +ve family history Inheritance  
Duchenne Muscular Dystrophy 2 X-linked  
Becker Muscular Dystrophy - - 
Limb Girdle Muscular Dystrophy 2  AR  
Myotonic dystrophy  - - 
Fascioscapulohumeral Muscular Dystrophy 1 AD 
             Inheritance is associated with muscle weakness. 
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Table 3: Cardiac involvement in Limbgirdle weakness 
Disease  Abnomal ECG  Echocardiography  
Duchenne Muscular Dystrophy 4 Normal  
Becker Muscular Dystrophy 1 Normal  
Limb Girdle Muscular Dystrophy 6 Cardiomyopathy  
Myotonic dystrophy  - - 
Fascioscapulohumeral Muscular Dystrophy - - 
          Limb Girdle Muscular Dystrophy has highest cardiac involvement with Cardiomyopathy. 
 
Table 4: Comparison between different subtypes of muscular dystrophies 
 Duchenne 
Muscular 
Dystrophy (n=14)  
Becker 
Muscular 
Dystrophy (n=4)  
Limb Girdle 
Muscular 
Dystrophy  (n=17)  
Fascioscapulohumeral 
Muscular Dystrophy (n=4)  
M:F 13:1 4:0 11:6 3:1 
Mean age of presentation  7yrs 19yrs  20yrs  25yrs  
Mean age of onset  4yrs  5yrs 3yrs  19 yrs  
Mean disease  duration  2yrs  4yrs  2yrs  4yrs  
Inheritance  x-linked (2)  -  AR (2)  AD (1)  
Calf hypertrophy  10 4 6 - 
EDB hypertrophy  10 3 5 - 
Valley sign(2) 6 1 6 - 
Scapular winging  6 - 8 5 
Hip abductor sign(3)  - - 10  - 
Mean CPK (ng/mL) 2687 2603 2881 1163 
Muscle biopsy  Dystrophic (70%) 
 myopathy (30%) 
Dystrophic (60%)  
Myopathy (40%)  
Dystrophic (80%)  
Myopathy (20%)  
Dystrophic (75%)  
Myopathy (25%)  
 
 
Table 5: Muscle Biopsy Findings 
 
 Duchenne 
Muscular 
Dystrophy 
(14)  
Becker 
Muscular 
Dystrophy 
(4)  
Limb Girdle 
Muscular 
Dystrophy  
(17)  
Fascioscapulohumeral 
Muscular Dystrophy (4)  
Myotonic 
dystrophy 
(3)  
Fiber size variation  14 4 17 3 1 
Central nuclei  4 1 10 1 - 
Round fibers  5 3 6 3 - 
Necrosis  - - 1 - - 
Split fibers  5 3 10 - 1 
Increased connective 
tissue  
6 - 3 2 2 
Atrophic fibers  4 - 5 - - 
Hypertrophi c fibers  6 4 15 4 2 
Angulated  - - - - - 
Lymphocytic 
infiltration  
3 - - 2 - 
 
DMD:; BMD: Becker Muscular Dystrophy; LGMD: Limb Girdle Muscular Dystrophy; FSHD: 
Fascioscapulohumeral Muscular Dystrophy; 
There were two cases of Myasthenia  gravis.  In all of the patients, the weakness started in the pelvic girdle 
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muscles followed by shoulder girdle weakness except 
in FSHD, in which hip girdle muscles were involved 
early.  15/68 of patients had only pelvic girdle muscle 
weakness at presentation.  
In two DMD cases deletion of dystrophin gene was 
identified. We could get positive family history in 5 of 
the cases of dystrophies. One case of FSHD had total 
asymmetry. 
Out of the five cases of metabolic myopathy, one 
female patient was on eptoin since the last nine years 
for generalized seizure disorder, one patient presented 
with vitamin D resistant rickets, there was one case of 
steroid induced myopathy [the patient was admitted for 
acute exacerbation of chronic bronchitis, was treated in 
ICU with ventilatory support, and developed proximal 
muscle weakness after recovery from illness], one 
female patient with polymyositis and in two other 
patients the cause for osteomalacia was not known.  
Discussion 
In our series, the maximum number of the cases with 
limb girdle weakness were due to muscle disorders 
[48/68] followed by neurogenic causes [18/68]. 
Out of 48 cases of muscle disorders LGMD [17/48] 
and DMD [14/48] formed the majority. The incidence 
and distribution of dystrophies correlated with previous 
Indian studies [Table 6]. 
Males were more affected in DMD and BMD. LGMD 
males outnumbered female patients in this study.  
Table 6: Comparison of muscular dystrophies in various other Indian studies 
 Present study  Das(4) et al  Srinivas(5) 
Limb Girdle Muscular Dystrophy 40.5% 29.2% 30% 
Duchenne Muscular Dystrophy 33.3% 30% 60% 
Becker Muscular Dystrophy 9.5% 6% - 
Fascioscapulohumeral Muscular 
Dystrophy 
9.5% 0.1% 2.5% 
 
Metabolic myopathies especially osteomalacia in 
females contributed to quite a good number of 
proximal muscle weakness cases. This type of 
osteomalacia is more common in asian peoples. The 
dysregulation of calcium metabolism in osteomalacia 
can manifest as muscle weakness[1]. Most cases of 
CIDP presented with predominant proximal muscle 
weakness. ECG changes were common, but 
echocardiography didn’t reveal any abnormality which 
is typical of Indian patients(6). Symptomatic cardiac 
involvement was seen only in one case. The low 
familial tendency [5 cases] noted in our study may be 
explained by the lack of ancestral information as in 
other studies[6].Since decades, across neuromuscular 
centers in India, dystrophies have been documented 
which were clearly distinct from the then well-
described dystrophinopathies, myotonic disorders, 
fascio-scapulo humeral dystrophies and the likes. 
Initial observations on LGMD in India were made in 
1975, when Srinivas, in a survey of 211 patients of 
myopathies seen over 25 years, diagnosed almost half 
the patients to have muscular dystrophy. Amongst 
them, 82 were Duchenne Muscular Dystrophy (DMD), 
35 LGMD, five fascio-scapulo humeral dystrophies 
and 14 ocular-oculopharyngeal myopathies.
 
[5]  In a 
hospital-based study of 126 cases of muscular 
dystrophy by Mondkar and Bhabha,
 
[7] 12 were 
designated as "girdle dystrophy" (three females) as 
they did not fit in Duchene or Becker muscular 
dystrophies. Four cases (three males) with affected 
sisters were labeled "Autosomal recessive dystrophy of 
childhood".  Das published a large series of 1950 
biopsy-proven myopathies, of which 535 were 
dystrophies. Among them, 29.2% were labeled as 
LGMDs, 5.6% severe dystrophies were seen in young 
girls, resembling DMD and 2.2% had autosomal 
recessive dystrophies in young boys.
 
[4] In the more 
recent times, immunocytochemical stains have been 
used to study Indian patients with LGMDs and 
information based on immunostaining has emerged. 
Initial case reports of "Adhalinopathy" (alpha-
sarcoglycanopathy) appeared in 2001.
 
[8,9,10] This 
was followed up by case reports of beta and gamma-
sarcoglycanoathy from pediatric centers in New 
Delhi.
 
[11,12] In 2002, the first series analyzing 25 
cases of sarcoglycanopathy came from a 
neuromuscular center in Mumbai, where phenotypic 
features were studied in detail and some unique 
features were pointed out.
 
[6] Soon, as more and more 
centers across the country got involved with 
immunostaining of myopathies, further reports, one 
from New Delhi in 2004, a study of 13 pediatric 
cases
 
[13] and the other from Hyderabad in 2007, 
detailing 26 adult cases of sarcoglycanopathies became 
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available.
 
[14]  Indeed, sarcoglycanopathy is the best 
characterized LGMD in India. The second type of 
LGMD to be immunocharacterized in India is 
dysferlinopathy. The initial series of 14 Indian patients 
with dysferlinopathy from Mumbai was published in 
2004.
 
[15] The second study comprising nine cases was 
recently reported from northern India by Pradhan in 
2008.
 
[16] A third series comprising 28 patients from 
south India has been made available in 2008.
 
[17] 
 Conclusion 
Our study reports that muscular dystrophies claim a 
major share of limb girdle weakness. However, as a 
hospital based study, our work only gives a glimpse of 
the true epidemiology of the diseases.  It shows that 
several conditions mimic myopathies, and hence it is 
very important to understand the precise etiology and 
to identify patients prone to life threatening cardiac, 
pharyngeal or respiratory muscle involvement. 
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